These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 24928472

  • 1. Serum under-O-glycosylated IgA1 level is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathy.
    Satake K, Shimizu Y, Sasaki Y, Yanagawa H, Suzuki H, Suzuki Y, Horikoshi S, Honda S, Shibuya K, Shibuya A, Tomino Y.
    BMC Nephrol; 2014 Jun 13; 15():89. PubMed ID: 24928472
    [Abstract] [Full Text] [Related]

  • 2. Increased binding of polymeric lambda-IgA to cultured human mesangial cells in IgA nephropathy.
    Lai KN, To WY, Li PK, Leung JC.
    Kidney Int; 1996 Mar 13; 49(3):839-45. PubMed ID: 8648928
    [Abstract] [Full Text] [Related]

  • 3. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.
    Shimozato S, Hiki Y, Odani H, Takahashi K, Yamamoto K, Sugiyama S.
    Nephrol Dial Transplant; 2008 Jun 13; 23(6):1931-9. PubMed ID: 18178603
    [Abstract] [Full Text] [Related]

  • 4. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy.
    Yasutake J, Suzuki Y, Suzuki H, Hiura N, Yanagawa H, Makita Y, Kaneko E, Tomino Y.
    Nephrol Dial Transplant; 2015 Aug 13; 30(8):1315-21. PubMed ID: 26109484
    [Abstract] [Full Text] [Related]

  • 5. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
    Tissandié E, Morelle W, Berthelot L, Vrtovsnik F, Daugas E, Walker F, Lebrec D, Trawalé JM, Francoz C, Durand F, Moura IC, Paradis V, Moreau R, Monteiro RC.
    Kidney Int; 2011 Dec 13; 80(12):1352-63. PubMed ID: 21866091
    [Abstract] [Full Text] [Related]

  • 6. Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.
    Gomes MM, Suzuki H, Brooks MT, Tomana M, Moldoveanu Z, Mestecky J, Julian BA, Novak J, Herr AB.
    Biochemistry; 2010 Jul 13; 49(27):5671-82. PubMed ID: 20507092
    [Abstract] [Full Text] [Related]

  • 7. Charge-dependent binding of polymeric IgA1 to human mesangial cells in IgA nephropathy.
    Leung JC, Tang SC, Lam MF, Chan TM, Lai KN.
    Kidney Int; 2001 Jan 13; 59(1):277-85. PubMed ID: 11135081
    [Abstract] [Full Text] [Related]

  • 8. Defective immunoglobulin A (IgA) glycosylation and IgA deposits in patients with IgA nephropathy.
    Kolka R, Valdimarsson H, Bodvarsson M, Hardarson S, Jonsson T.
    APMIS; 2013 Sep 13; 121(9):890-7. PubMed ID: 23398317
    [Abstract] [Full Text] [Related]

  • 9. Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy.
    Camilla R, Suzuki H, Daprà V, Loiacono E, Peruzzi L, Amore A, Ghiggeri GM, Mazzucco G, Scolari F, Gharavi AG, Appel GB, Troyanov S, Novak J, Julian BA, Coppo R.
    Clin J Am Soc Nephrol; 2011 Aug 13; 6(8):1903-11. PubMed ID: 21784819
    [Abstract] [Full Text] [Related]

  • 10. Pathogenesis of IgA nephropathy.
    Feehally J, Allen AC.
    Ann Med Interne (Paris); 1999 Feb 13; 150(2):91-8. PubMed ID: 10392257
    [Abstract] [Full Text] [Related]

  • 11. O-glycosylation of serum IgD in IgA nephropathy.
    Smith AC, de Wolff JF, Molyneux K, Feehally J, Barratt J.
    J Am Soc Nephrol; 2006 Apr 13; 17(4):1192-9. PubMed ID: 16510764
    [Abstract] [Full Text] [Related]

  • 12. Glucocorticoids Reduce Aberrant O-Glycosylation of IgA1 in IgA Nephropathy Patients.
    Kosztyu P, Hill M, Jemelkova J, Czernekova L, Kafkova LR, Hruby M, Matousovic K, Vondrak K, Zadrazil J, Sterzl I, Mestecky J, Raska M.
    Kidney Blood Press Res; 2018 Apr 13; 43(2):350-359. PubMed ID: 29529610
    [Abstract] [Full Text] [Related]

  • 13. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
    Berthelot L, Robert T, Vuiblet V, Tabary T, Braconnier A, Dramé M, Toupance O, Rieu P, Monteiro RC, Touré F.
    Kidney Int; 2015 Oct 13; 88(4):815-22. PubMed ID: 26061544
    [Abstract] [Full Text] [Related]

  • 14. Serum Levels of Joining Chain-Containing IgA1 Are Not Elevated in Patients with IgA Nephropathy.
    Li G, Wang X, Yang Z, Zhao Q, Wen Y, Li X, Gao R.
    Dis Markers; 2019 Oct 13; 2019():9802839. PubMed ID: 31354895
    [Abstract] [Full Text] [Related]

  • 15. Difference in IgA1 O-glycosylation between IgA deposition donors and IgA nephropathy recipients.
    Nakazawa S, Imamura R, Kawamura M, Kato T, Abe T, Namba T, Iwatani H, Yamanaka K, Uemura M, Kishikawa H, Nishimura K, Oka K, Tajiri M, Wada Y, Nonomura N.
    Biochem Biophys Res Commun; 2019 Jan 22; 508(4):1106-1112. PubMed ID: 30553446
    [Abstract] [Full Text] [Related]

  • 16. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.
    Novak J, Moldoveanu Z, Renfrow MB, Yanagihara T, Suzuki H, Raska M, Hall S, Brown R, Huang WQ, Goepfert A, Kilian M, Poulsen K, Tomana M, Wyatt RJ, Julian BA, Mestecky J.
    Contrib Nephrol; 2007 Jan 22; 157():134-8. PubMed ID: 17495451
    [Abstract] [Full Text] [Related]

  • 17. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin.
    Linossier MT, Palle S, Berthoux F.
    Am J Kidney Dis; 2003 Mar 22; 41(3):558-64. PubMed ID: 12612978
    [Abstract] [Full Text] [Related]

  • 18. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
    Moura IC, Arcos-Fajardo M, Gdoura A, Leroy V, Sadaka C, Mahlaoui N, Lepelletier Y, Vrtovsnik F, Haddad E, Benhamou M, Monteiro RC.
    J Am Soc Nephrol; 2005 Sep 22; 16(9):2667-76. PubMed ID: 15987753
    [Abstract] [Full Text] [Related]

  • 19. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity.
    Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, Chatham WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, Lee JY, Robinson J, Tomana M, Tomino Y, Mestecky J, Novak J.
    J Clin Invest; 2009 Jun 22; 119(6):1668-77. PubMed ID: 19478457
    [Abstract] [Full Text] [Related]

  • 20. O- and N-Glycosylation of Serum Immunoglobulin A is Associated with IgA Nephropathy and Glomerular Function.
    Dotz V, Visconti A, Lomax-Browne HJ, Clerc F, Hipgrave Ederveen AL, Medjeral-Thomas NR, Cook HT, Pickering MC, Wuhrer M, Falchi M.
    J Am Soc Nephrol; 2021 Oct 22; 32(10):2455-2465. PubMed ID: 34127537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.